| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |